58 studies found for:    BUTYRYLCHOLINESTERASE
Show Display Options
Rank Status Study
21 Completed Effects of Donepezil on Deficits Associated With Age-Related Decrease of Growth Hormone
Condition: Elderly
Intervention: Drug: Donepezil
22 Unknown  CALM-AD
Condition: Alzheimer's Disease
Intervention: Drug: Donepezil
23 Completed
Has Results
A Study to Test the Performance of the CogState Computerized Neuropsychological Battery in Patients With Alzheimer's Disease (0000-086)(COMPLETED)
Condition: Alzheimer's Disease
Interventions: Drug: Comparator: Placebo 5mg (run in);   Drug: Donepezil 5 - 10 mg;   Drug: Comparator: Placebo 5-10 mg;   Drug: Donepezil 10 mg
24 Completed Use of Donepezil for Treatment of Cocaine Dependence
Condition: Cocaine Abuse and Dependence
Intervention: Drug: Donepezil, 5 mg daily
25 Active, not recruiting Efficacy and Safety of TV-1380 as Treatment for Facilitation of Abstinence in Cocaine-Dependent Subjects
Condition: Cocaine Addiction
Interventions: Drug: TV-1380 150 mg;   Drug: TV-1380 300 mg;   Drug: Placebo
26 Withdrawn Tacrine Effects on Cocaine Self-Administration and Pharmacokinetics
Condition: Cocaine Dependence
Interventions: Drug: Oral tacrine;   Drug: Oral placebo
27 Completed Evaluation of Three Potential Central Nervous System (CNS) Pretreatments for Soman Exposure on Human Performance
Condition: Biomarkers, Pharmacological
Interventions: Drug: Huperzine A;   Drug: Donepezil;   Drug: Galantamine;   Other: Placebo
28 Completed Combined Donepezil and Selegiline Effects on Cocaine-Reinforced Behavior
Condition: Cocaine Use Disorders
Interventions: Drug: High-dose donepezil;   Drug: Low-dose donepezil;   Drug: Selegiline;   Drug: Placebo
29 Completed
Has Results
Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD)
Condition: Parkinson's Disease Dementia
Interventions: Drug: Rivastigmine capsule;   Drug: Rivastigmine transdermal patch
30 Completed Exercise Treatment of Mild-Stage Probable Alzheimer's Disease
Conditions: Alzheimer Disease;   Memory Disorders;   Dementia
Interventions: Behavioral: Participation in a monitored exercise program;   Behavioral: Personalized aerobic and strength training.
31 Completed A Study to Determine the Clinical Safety/Tolerability and Exploratory Efficacy of EHT 0202 as Adjunctive Therapy to Acetylcholinesterase Inhibitor in Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: EHT 0202 etazolate;   Drug: Placebo
32 Completed
Has Results
A 24 Week, Multicenter, Open, Evaluation of the Clinical Effectiveness of the Once-daily 10 cm^2 Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease (EXTRA)
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine transdermal patch
33 Unknown  The Effect of Donepezil on Gait and Balance in Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: Donepezil
34 Recruiting Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly
Conditions: Alzheimer Disease;   Mild Cognitive Impairment;   Delirium, Dementia, Amnestic, Cognitive Disorders
Intervention: Drug: Donepezil
35 Recruiting Safety Study of Pyridostigmine in Heart Failure
Condition: Heart Failure
Intervention: Drug: Pyridostigmine Bromide
36 Completed Efficacy and Tolerability of MLC601 in Patients With Mild to Moderate Alzheimer Disease Who Were Unable to Tolerate or Failed to Benefit From Treatment With Rivastigmine
Condition: Alzheimer Disease
Intervention: Drug: MLC601
37 Recruiting Rivastigmine Patch in Veterans With Cognitive Impairment Following TBI
Conditions: Traumatic Brain Injury;   Cognitive Impairment
Intervention: Drug: Rivastigmine Transdermal Patch
38 Completed Efficacy Study of a ZT-1 Implant in Patients Suffering From Alzheimer's Disease
Condition: Moderate Alzheimer's Disease
Interventions: Drug: ZT-1;   Drug: Donepezil
39 Completed Long-term Safety and Efficacy of Galantamine in Alzheimer's Disease
Condition: Alzheimer Disease
Intervention: Drug: galantamine
40 Recruiting Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydrochloride 10 mg Treatment in Japanese Subjects With Severe Alzheimer's Disease
Condition: Alzheimer's Type Dementia
Intervention: Drug: E2020

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-58) Show next page of results
Indicates status has not been verified in more than two years